Photocure, Inc.
Princeton, NJ Photocure, Inc. - US Cancer
- UEI
- HEK3DJVGPGX6
- CAGE
- 6D1T9
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 202 Carnegie Center Dr #101, Princeton, NJ 08540, USA
- Website
- photocure.com
- Founded
- 1993
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Fennec Pharmaceuticals, Inc. | Durham, NC | 325412 Pharmaceutical Preparation Manufacturing |
| Urogen Pharma Inc. | Princeton, NJ | 325414 Biological Product (except Diagnostic) Manufacturing |
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| Servier Pharmaceuticals LLC | Boston, MA | 325412 Pharmaceutical Preparation Manufacturing |
| U.s. Division | Rockville, MD | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
About the company
Photocure, Inc. is a foreign-owned, for-profit corporation headquartered in the US with a cancer division dedicated to improving bladder cancer management. According to its website, Photocure delivers transformative solutions to improve the lives of bladder cancer patients.
Photocure, Inc. has been awarded prime federal contracts by the Department of Veterans Affairs and the Department of Health and Human Services to supply the drug Cysview, an optical imaging agent used for detecting bladder cancer. The VA contract, a delivery order against Photocure's GSA Schedule for pharmaceuticals, was for over $71,000 worth of Cysview vials. The HHS contract, a purchase order from the NIH Clinical Center, procured nearly $8,000 of Cysview. Both contracts did not designate any type of set-aside.
Photocure, Inc. currently holds a Federal Supply Schedule IDV contract awarded by the VA VHA VISN 12 for drugs, pharmaceuticals, and hematology-related products under Schedule 65 IB. This multiple-award IDV has a potential value exceeding $8.8 million through August 2028. While specific products were not listed, the contract likely encompasses chemotherapy drugs, blood products, growth factors, and associated pharmaceuticals to support healthcare services across the VA medical system. No set-asides were designated for this pre-qualified vehicle.
Quick answers
Is Photocure, Inc. registered in SAM.gov?
Yes. Photocure, Inc.'s SAM.gov registration is active through March 20, 2027.
Which contract vehicles does Photocure, Inc. hold?
Photocure, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Photocure, Inc.'s most recent federal award?
Photocure, Inc.'s most recent federal contract award is Cysview (hexaminolevulinate HCL) 100MG/vial kit (36C25521F0088), from Veterans Integrated Service Network 15 (VHA), on July 1, 2021.
On GovTribe
See Photocure, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors